Print ISSN:-2581-8112

Online ISSN:-2581-9151

CODEN : IIJOAT

Article History

Received : 05-04-2024

Accepted : 10-05-2024



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 380

PDF Downloaded: 161


Comparative study between hyaluronic acid & platelet rich plasma in treatment of knee osteoarthritis


Full Text PDF


Original Article

Author Details : Chinmoy Das, Partha Pratim Das, Aniruddha Indra*

Volume : 10, Issue : 1, Year : 2024

Article Page : 30-35

https://doi.org/10.18231/j.ijor.2024.007



Suggest article by email

Get Permission

Abstract

Background: Knee osteoarthritis (OA) is a prevalent degenerative joint condition. This study aims to compare the therapeutic potential of Hyaluronic Acid (HA) and Platelet Rich Plasma (PRP) in its management.
Materials and Methods : A comparative study was conducted with patients receiving either HA or PRP injections. Outcome measures included VAS and WOMAC scores, safety profiles, patient satisfaction, and requirement for repeat injections.
Results : PRP-treated patients exhibited superior improvement in VAS and WOMAC scores by the 12-month mark. Adverse reactions were minimal and comparable between groups. Notably, 92% of PRP recipients expressed a willingness for repeat treatment. PRP-treated patients also showcased prolonged therapeutic benefits, with fewer requiring subsequent injections.
Conclusion: PRP outperforms HA in multiple domains, emphasizing its potential as a more effective treatment for knee OA.
 

Keywords: Knee osteoarthritis, Platelet Rich Plasma, Hyaluronic Acid, VAS score, WOMAC score



How to cite : Das C, Das P P, Indra A, Comparative study between hyaluronic acid & platelet rich plasma in treatment of knee osteoarthritis. IP Int J Orthop Rheumatol 2024;10(1):30-35


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution 4.0 International License, which allows others to remix, and build upon the work, the licensor cannot revoke these freedoms as long as you follow the license terms.